Healthcare -
Biotechnology - NASDAQ - US
$ 20.72
-1.57 %
$ 1.8 B
Market Cap
-4.58
P/E
TVTX - COST OF REVENUE
Cost of Revenue TVTX - Travere Therapeutics, Inc.
11.4 M
LAST VALUE
29.92%
2 YEAR CAGR
15.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR